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ABSTRACT 
 
AIM: The purpose of this prospective, randomized, triple-blind study was to 
compare the anaesthetic efficacy of 2 % lidocaine + 1:80,000 epinephrine and 4 % 
articaine + 1:1,00,000 epinephrine buffered with 0.5 mol/l mannitol or 8.4 % sodium 
bicarbonate on the success of inferior alveolar nerve block for teeth with 
symptomatic irreversible pulpitis. 
 
MATERIALS AND METHODS: 180 adult patients diagnosed with symptomatic 
irreversible pulpitis of a mandibular posterior tooth were randomly divided into 6 
groups of 30 participants in each group. The patients received 1 cartridges of either 
2 % lidocaine + 1:80,000 epinephrine or 4 % articaine + 1:1,00,000 epinephrine 
buffered  buffered with 0.5 mol/l mannitol or 8.4 % sodium bicarbonate using 
conventional IAN block injections. Endodontic access preparation was initiated 15 
minutes after injection. Pain on injection, pain on access preparation & pain on 
instrumentation was measured using Heft-Parker visual analog scale. Data were 
analyzed by the descriptive statistics, one way ANOVA & Tukeys post hoc tests. 
 
RESULTS: There was no significant difference among any groups for pain on 
injection. Buffered local anaesthetics showed higher success rates compared to 
nonbuffered groups and articaine showed better efficacy than lignocaine in both 
buffered and non buffered groups for pain on acess opening & pain on 
instrumentation. 
 
CONCLUSION : Buffered local anaesthetic solutions found to be promising in 
reducing pain. 0.5mol/L Mannitol and 8.4 % sodium bicarbonate proved that adding 
these buffering agents will improve the anaesthetic efficacy of 4 % articaine + 
1:1,00,000 epinephrine than 2 % lignocaine + 1:80,000 epinephrine. 4 % articaine + 
1:1,00,000 epinephrine performed better than 2 % lignocaine + 1:80,000 epinephrine 
in reducing pain. 
 
KEY WORDS: Lignocaine, Articaine, Buffered Local Anaesthetic solution, 8.4 % 
Sodium Bicarbonate, 0.5 mol/L Mannitol. 
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INTODUCTION 
Local anaesthetic to reach pulp for profound pulpal anaesthesia is difficult in 
dentistry and also in Endodontics, In Endodontic practice adequate pulpal anaesthesia 
is a mandatory requirement for painless root canal treatment which involves the 
extirpation of pulp. Patient may experience intolerable pain if adequate pulpal 
anaesthesia is not achieved and doing a root canal treatment will be very difficult in 
such cases.  
Currently Lignocaine is the most widely used local anaesthetic in endodontics 
throughout the world. First introduced by Löfgren and Lundquist in 1943, it has its 
potency fourfold greater than that of procaine, and toxicity double than that of procaine. 
Because of its good diffusibility, early onset of action, practitioners prefer lignocaine as 
their first choice of local anaesthetic solution in dentistry as well as in Endodontics
81
. 
Vasoconstrictors are added to local anaesthetic solutions to slow down the 
absorption rate and prolonging the duration of action, also reduces the toxicity of 
anaesthetics. Therefore, it is necessary to take into consideration that chances of 
reactive vasodilatation is more after surgery with usage of local anaesthetics with added 
vasoconstrictors. It also contributes in the acidic nature of the local anaesthetic solution 
directly. 
To promote solubility and to increase shelf life, Local anaesthetic solutions are 
manufactured at a pH around 3.9. Pain on injection is one factor associated with the 
acidic nature of local anaesthetic solution. When we deposite such acidic solution, body 
neutralize that solution to physiologic pH to increase the availability of non ionized 
base form of local anaesthetic molecule for effective anaesthesia of the particular area. 
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Considering the available literature on use of local anaesthesia in endodontics, 
inferior alveolar nerve block for mandibular anaesthesia has highest failure rate ranging 
44-81 %
13
. In general, most possible reason for failure is that difficulty for the local 
anaesthetic molecule to penetrate the perineural barrier around the nerve. Specifically 
for inferior alveolar nerve block failure, the causes include anatomical difficulty in 
depositing the solution exactly, accessory innervations, cross innervations, needle 
deflection and inflammatory mediators sensitizing sodium channels being resistant to 
lignocaine
98
. 
Many studies have been performed with the goal to increase success rates of the 
IANB. Researchers have studied adding hyaluronidase to the anaesthetic solution
117
, 
adding carbonation to the anaesthetic solution
22
, using dyphenhydramine as an 
anaesthetic solution
144,27,
, using 0.5 % bupivacaine
41
, using 3 % mepivacaine and 4 % 
prilocaine
92
, using articaine
94
, administering the block using a peripheral nerve 
stimulator for accurate placement
128
, changing the epinephrine concentration
34,149
, 
administering more anaesthetic
43
, changing the amount and concentration of 
lidocaine
141
, or combining meperidine and lidocaine
13
. Interestingly, none of these 
studies were able to show significant increase in the success rate of the IANB. 
In order to improve the anaesthetic efficacy of inferior alveolar nerve block 
researchers have tried articaine as alternative because of its properties as  achieving 
highest level of anaesthetic potency and lowest systemic toxicity. Thus, articaine said to 
be the local anaesthetic of superior value in tissues with suppurative inflammation, for 
adults, children, pregnant women, breastfeeding women, patients suffering from hepatic 
disorders and renal function impairment
25
. 
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Further to increase the anaesthetic efficacy of local anaesthetic molecules, 
buffering or alkalanization of local anaesthetic molecules have been tried. Buffered 
local anaesthetics have a higher pH and may be more efficient in achieving pain control 
for the inferior alveolar nerve block. Amide local anaesthetics, such as lidocaine, have a 
weak base component. Lidocaine with epinephrine is a mixture of two chemical forms: 
a de-ionized, uncharged free base form and an ionized, charged cationic form
9
. The de-
ionized form of the local anaesthetic is the active lipid-soluble form that readily enters 
the nerve membrane and blocks nerve conduction
62
. The presence of a sufficient 
amount of de-ionized free base anaesthetic is necessary to induce adequate anaesthesia.  
Catchlove
20
. studied the influence of CO2 and pH on local anaesthetic action, the 
addition of sodium bicarbonate to LAs will result in the production of carbon dioxide 
and water. They concluded that “carbon dioxide  potentiates local anaesthesia by three 
mechanisms: a direct depressant effect of carbon dioxide on the axon, by concentrating 
local anaesthetic inside the nerve trunk, and by decreasing the pH inside the nerve 
which will allow a greater conversion of anaesthetic to its active cation form once inside 
the membrane”. 
Antonijevic et al found that a 0.5 mol/L solution of mannitol was most effective 
in opening the perineural membrane to allow for enhanced penetrability of 
macromolecules and/or ions. They demonstrated that the efficacy of both hydrophilic 
and lipophilic compounds could be improved dramatically by the concomitant alteration 
of perineural permeability
6
. 
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 No study has investigated the comparative evaluation of anaesthetic efficacy of  
2 % lidocaine + 1:80,000 epinephrine and 4 % articaine + 1:1,00,000 epinephrine 
buffered with 0.5 mol/l mannitol or 8.4 % sodium bicarbonate on the success of 
inferior alveolar nerve block for teeth with symptomatic irreversible pulpitis. 
Therefore, the purpose of this prospective, randomized, triple-blind study is to 
determine and compare the effect of non buffered lignocaine and articaine with 
buffered lignocaine and articaine using mannitol or sodium bi carbonate as buffers on 
the anaesthetic success of the inferior alveolar nerve block in patients experiencing 
symptomatic irreversible pulpitis. 
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AIMS AND OBJECTIVES 
Aim(s) of the study:  
To Compare the Efficacy of two local anesthetic solutions buffered with 
two buffering agents to assess the pain on injection, access opening and 
endodontic instrumentation on the success of inferior alveolar nerve block for teeth 
with symptomatic irreversible pulpitis. 
 
Objective(s) of the study:  
To assess and compare, 
1. anesthetic efficacy of 2 % lidocaine + 1:80,000 epinephrine. 
2. anesthetic efficacy of 4 % articaine + 1:1,00,000 epinephrine.  
3. anesthetic efficacy of 2 % lidocaine + 1:80,000 epinephrine buffered with 8.4 % 
sodium bicarbonate. 
4. anesthetic efficacy of 2 % lidocaine + 1:80,000 epinephrine buffered with 0.5 mol/l 
mannitol. 
5. anesthetic efficacy of 4 % articaine + 1:1,00,000 epinephrine buffered with 8.4 % 
sodium bicarbonate. 
6. anesthetic efficacy of 4 % articaine + 1:1,00,000 epinephrine buffered with         
0.5 mol/L mannitol. 
On the success of inferior alveolar nerve block for teeth with symptomatic irreversible 
pulpitis by Heft-parker visual analogue scale on the pain on injection, access opening 
and endodontic instrumentation. 
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REVIEW OF LITERATURE 
LIGNOCAINE 
Peterson et al (1977)
106
 compared anaesthetic efficacy of four solutions, 
mepivacaine with or without epinephrine, prilocaine and lignocaine via 
maxillary infiltration and IAN block. Anaesthesia achieved via infiltration was 
56-100 % and via IAN block 56-90 %. 
Kaufman et al (1984)
68
 compared lignocaine with or without 
epinenephrine, bupivacaine and saline via PDL injection of maxillary lateral 
incisor. No anaesthesia was produced via the saline solution and lignocaine with 
epinephrine produced longest pulpal anesthesia. 
Johnson et al (1985)
64
 compared PDL injections (0.4 ml) of etidocaine 
and lignocaine of maxillary canine teeth. No significant difference in anaesthetic 
success were noted between the two solutions. 
Handler et al (1987)
53
 evaluated the effects of the vasoconstrictor 
epinephrine on the duration of pulpal anesthesia using the PDL injections (0.2 
ml of all the test solutions). There was no statistical difference in the ability of 
lidocaine, lidocaine with epinephrine 1:50,000, lidocaine with epinephrine 
1:100,000, and epinephrine 1:100,000, including epinephrine alone to produce 
anesthesia. 
Edwards et al (1989)
38
 evaluated the effectiveness of PDL injections 
(0.8 ml) using lignocaine epinephrine or saline. Lignocaine was significantly 
more effective in providing anesthesia (79 %) while PDL injections of saline or 
epinephrine provided 0 % anaesthetic success. 
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Chaney et al (1991)
23
 compared three formulations of lignocaine 
(hydrochloride vs hydrocarbonate with or without epinephrine) for IAN block 
(1.8 ml).The aneasthetic success for the plain lignocaine hydrocarbonate 
solution was less than 10 % and the remaining two solutions were ranged in 
success from 37-63% and difference were not significant. 
Mclean et al (1992)
93
 compared bupivacaine to lignocaine using the 
PDL injection (0.8 ml). No significant difference in success rate between 
lignocaine & bupivacaine was evident ( 38 vs 33 % respectively) 
Nist et al (1992)
97
 evaluated the incisive nerve block ( 1.8 ml ) and 
combination of IAN block (3.6 ml) and incisive nerve blocks with lignocaine . 
The incisive nerve block alone did not result in successful anesthesia in the 
central, lateral. The combination with IAN block was successful in the 1
st
 and 
2
nd
 premolar and enhanced anaesthesia for laterals and 1
st
 molar. 
Mclean et al (1993)
92
 compared prilocaine, mepivacaine and lignocaine 
for IAN block (1.8 ml). No significant difference in onset or success were found 
among the solutions. 
Cohen et al (1993)
29
 compared  lignocaine and mepivacaine when given 
via IAN block (1.8 ml) for teeth with irreversible pulpities. Both lignocaine and 
mepivacaine IAN block resulted in 55 % success. 
Coggins et al (1996 )
28 
 Evaluated the anaesthetic efficacy of the intra 
osseous (IO) injection (1.8 ml lignocaine) as a primary technique in maxillary 
and mandibular 1
st
 molars and lateral incisor. Anaesthetic success rate is 75 % 
and 78 % of mandular 1
st
 molar and lateral incisor respectively. For maxillary 
first molar and lateral incisor, these values were 93 % and 90 % respectively. 
REVIEW OF LITERATURE 
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Childer et al (1996)
24
 evaluated the contribution of the PDL injection 
(0.4 ml) to the success of IAN block (1.8 ml) in mandibular 1
st
 molar with 
lignocaine. Incidence of successful pulpal anaesthesia was greater for the 
combination of injection for the 1
st
       23 minutes of testing but difference were 
not significant after this point. 
Replodge et al (1997)
115
 compared primary IO injection of lignocaine or 
mepivacaine in mandibular 1
st
 molar. Lignocaine resulted in a significantly 
higher rate of success than mepivacaine (75 % vs 45 %). 
Vangheluwe et al (1997)
140
 compared administering solutions of 
lignocaine or saline via intra pulpal delivery for supplemental anaesthesia for 
patients with irreversible pulpitis, overall 33 of 35 injections effective, 
suggesting that success is not solution dependent. 
Reitz et al (1998)
114
 evaluated the effect of repeated IO injection (0.9 
ml) given 30 min following a combination of IAN block (1.8 ml) and IO 
injection (0.9 ml) in mandibular posterior teeth with lignocaine ). The repeated 
IO injection did not result in an increase in duration of pulpal anaesthesia of 6-
14 min, although this was not stastically significant. 
Clark et al (1999)
26
 compared the efficacy of IAN block of 3.6 ml 
lignocaine with or without the addition of a mylohyoid nerve block of 1.8 ml 
lignoocaine. There was no significant increase in success with the addition of 
the mylohyoid nerve block to an IAN block. 
Ridenour et al (2001)
117
 compared lignocine to lignocaine plus 
hyaluronidase solution in IAN block. There was no significant difference 
REVIEW OF LITERATURE 
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between the two solution. But the addition of hyaluronidase resulted in an 
increase in post operative pain and trismus. 
Yonchak et al(2001)
150
 evaluated anaesthetic success obtained with 
unilateral or bilateral IAN block using 3.6 ml of lignocaine for each block. 
Success rate for bilateral IAN block were significantly higher for the central 
incisor (39 % vs 66 %) and canine   (68 % vs 76 %) than for the unilateral block. 
Kennedy et al (2003)
69
 evaluated the significance of needle deflection 
on the success of IAN blocks using 2.8 ml lignocaine on patients with IP. No 
significant difference were observed on success rates using a conventional IAN 
block when compared with a bidirectional needle rotation technique. 
Whitcomb M et al ( 2010)
143
  randomly administered inferior alveolar 
nerve (IAN) blocks using a buffered 2 % lignocaine with 1: 100,000 
epinephrine/sodium bicarbonate formulation and an unbuffered 2 % lignocaine 
with 1: 100,000 epinephrine formulation at 2 separate appointments spaced at 
least 1week apart using crossover design. They concluded that buffering a 2 % 
lignocaine with 1: 100,000 epinephrine with sodium bicarbonate did not 
statistically increase anaesthetic success, provide faster onset, or result in less 
pain of injection when compared with unbuffered 2 % lignocaine with 1: 
100,000 epinephrine for an IAN block. 
Wolf R et al (2011)
146
 Conducted randomized, single-blind study to 
determine the anaesthetic efficacy of lignocaine with epinephrine & compared to 
lignocaine with epinephrine plus 0.5 M mannitol in inferior alveolar nerve 
blocks. Forty subjects randomly received an IAN block in 3 separate 
appointments with following formulations:  A 1.8 mL solution of 36 mg 
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lignocaine with 18 mg epinephrine (control solution): A 2.84 mL solution of 36 
mg lignocaine with 18 mg epinephrine (1.80 mL) plus 0.5 M mannitol (1.04 
mL); and a 5 mL solution of 63.6 mg lignocaine with 32 mg epinephrine (3.18 
mL) plus 0.5 M mannitol (1.82 mL). The results showed that 2.84 mL of 
lignocaine with epinephrine plus 0.5 M mannitol was significantly better than1.8 
mL of lignocaine with epinephrine for the molars and premolars. The 5 mL of 
lignocaine with epinephrine plus 0.5 M mannitol was statistically better than1.8 
mL of lignocaine with epinephrine and 2.84 mL of lignocaine with epinephrine 
plus 0.5 mol/L mannitol for all teeth except the central incisor. They concluded 
adding 0.5 M mannitol to lignocaine with epinephrine formulations significantly 
improved effectiveness in achieving a greater percentage of total pulpal 
anesthesia as compared with a lignocaine formulation without mannitol for IAN 
block. 
Aggarwal V et al (2011)
5
 evaluated the effect of ketorolac & 
dexamethasone infiltration along with standard IANB on the success rate. 
Ninety-four adult were selected. All patients received standard IANB of 2 % 
lignocaine with 1:200,000 epinephrine. Among this Twenty-four patients did not 
receive any supplemental infiltrations (control) whereas Twenty-four patients 
received supplemental buccal infiltration of 4 % articaine with 1:100,000 
ephinephrine, and rest of the patients received supplemental buccal infiltration 
of 1 mL/4 mg of dexamethasone. Result showed Supplementary dexamethasone 
infiltration gave 45% success rate, which was insignificant with control IANB. 
They concluded Articaine and ketorolac infiltration can increase the success rate 
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of IANB in patients with irreversible pulpitis. None of the tested techniques 
gave 100 % success rate. 
Kreimer T et al ( 2012)
23
 Determined the anaesthetic efficacy of 
lignocaine with epinephrine compared with a combination of lignocaine with 
epinephrine plus 0.5 mol/L mannitol for inferior alveolar nerve blocks in 
patients experiencing symptomatic irreversible pulpitis. 55 emergency patients  
were randomly received IAN blocks by using a 3.18- mL formulation containing 
63.6 mg of lignocaine with 31.8 mg epinephrine or a 5-mL formulation 
containing 63.6 mg of lignoocaine with 31.8 mg epinephrine plus 1.82 mL of 
0.5 mol/L mannitol. The result showed 1.9 mL of lignocaine (76.4 mg) with 
epinephrine plus 0.5 mol/L mannitol had a significantly better success rate of 39 
% when compared with the lignocaine formulation without mannitol. They 
Concluded for mandibular posterior teeth in patients with symptomatic 
irreversible pulpitis, the addition of 0.5 mol/L mannitol to 1.9 mL of lignocaine 
with epinephrine resulted in a statistically higher success rate whereas the 
combination of lignocaine/ mannitol formulation would not result in predictable 
pulpal anesthesia. 
Sampaio RM et al (2012)
121
 compared the anaesthetic efficacy of 0.5 % 
bupivacaine with 1:200,000 epinephrine with that of 2 % lignocaine with 
1:100,000 epinephrine during pulpectomy in patients with irreversible pulpitis in 
mandibular posterior teeth. All patients reported the lip anesthesia after the 
application of both the solutions. By measuring pulpal anesthesia success with 
the pulp tester, lignocaine had a higher success rate than bupivacaine. They 
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concluded neither of the solutions resulted in an effective pain control during 
irreversible pulpitis treatments of mandibular molars. 
Kanaa MD et al (2012)
25
 Compared the efficacy of supplementary 
repeat inferior alveolar nerve block with 2 % lignocaine & epinephrine, buccal 
infiltration with 4 % articaine with epinephrine, intraligamentary injection or 
intraosseous injection after failed inferior alveolar nerve block for securing pain-
free treatment in patients experiencing irreversible pulpitis in mandibular 
permanent teeth. Patients were received 2.0 mL of 2 % lignocaine with 1:80,000 
epinephrine as an IANB injection. They concluded inferior alveolar nerve block 
injection alone does not always allow pain-free treatment for mandibular teeth 
with irreversible pulpitis. Supplementary buccal infiltration with 4 % articaine + 
epinephrine and intraosseous injection with 2 % lignocaine  with  
intraligamentary and repeat inferior alveolar nerve block injections with 2 % 
lignocaine with epinephrine for patients experiencing irreversible pulpitis in 
mandibular permanent teeth. 
Aggarwal V et al (2012)
3
 Evaluated the anaesthetic efficacy of 1.8 mL 
and 3.6 mL of 2 % lignocaine with 1:200,000 epinephrine in patients with 
irreversible pulpitis. Fifty-five adults were selected and divided into two groups 
on a random basis & received an inferior alveolar nerve block with either 1.8 
mL or 3.6 mL of 2 % lignocaine with 1:200,000 epinephrine. They found  no 
significant differences in sex, age, or preoperative pain scores of the 
experimental groups. They concluded the increasing the volume of 2 % 
lignocaine to 3.6 mL improved the success rate as compared with 1.8 mL but did 
not give a clinical success rates of 100 %. 
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Kreimer T et al (2012)
70
 Studied to determine the anaesthetic efficacy 
of lignocaine with epinephrine compared with a combination lignocaine with 
epinephrine plus 0.5 mol/L mannitol for inferior alveolar nerve blocks in 
patients experiencing symptomatic irreversible pulpitis. They concluded that the 
addition of 0.5 mol/L mannitol to 1.9 mL of lignocaine (76.4 mg) with 
epinephrine resulted in a statistically higher success rate. Whereas the 
combination, lignocaine and mannitol formulation would not result in 
predictable pulpal anesthesia. 
Thimmaiah PB et al (2013)
134
  Determined the anaesthetic efficacy of 2 
% lignocaine with 1: 80,000 epinephrine & 0.5 mol/ L manitol in inferior 
alveolar nerve blocks in patients with symptomatic irreversible pulpitis. 60 
subjects randomly received inferior alveolar nerve blocks using two solutions, 
2.5 ml of 2 % lignocaine with 1:80,000 epinephrine whereas other composed of 
1.6 ml of lignocaine with 1:80,000 epinephrine & 0.9ml of 0.5 mol/L manitol. 
They concluded that combination of local anaesthetic and mannitol should be 
used on regular basis to obtain successful anesthesia . 
Hobeich P et al (2013)
63
 compared the anaesthetic onset & pain on 
maxillary infiltration injection of 2 % lignocaine with 1:1,00,000 epinephrine 
and 2 % lignocaine with 1:1,00,000 epinephrine buffered with 5 % and 10 % 
sodium bicarbonate by volume. Thirty subjects with intact maxillary canines 
were selected. 1 of the 3 maxillary infiltration injections of 1.8 mL 2 % 
lignocaine with 1:1,00,000 epinephrine and 2 % lignocaine with 1:1,00,000 
epinephrine buffered at 5 % and 10 % with sodium bicarbonate by volume at 3 
separate appointments. They concluded that Two percent lignocaine with 
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1:1,00,000 epinephrine buffered with 5 % or 10 % sodium bicarbonate did not 
differ from non buffered solutions in anaesthetic onset or injection pain in 
maxillary infiltrations of canines with healthy pulps. 
Aggarwal V et al (2013)
4
 Evaluated the anaesthetic efficacy and 
injection pain of 1.8 mL of 2 % lignocaine with different concentrations of 
epinephrine (1 : 80,000 and 1 : 2,00,000) in patients with symptomatic 
irreversible pulpitis. Sixty-two adults were actively experiencing pain, & were 
randomly allocated into 2 groups & received 1.8 mL of 2 % lignocaine with 
either 1 : 80,000 or 1 : 2,00,000 epinephrine concentration. They concluded that 
two percent lignocaine solution used for inferior alveolar nerve block  achieved 
similar success rates when used with 1 : 80,000 or 1 : 2,00,000 epinephrine 
concentration. 
Balasco M et al (2013)
8
 compared the pain of infiltration and pain of an 
incision and drainage procedure by using a buffered versus a non buffered  
solution of 2 % lignocaine with 1:100,000 epinephrine solution in symptomatic 
patients with a diagnosis of pulpal necrosis and acute swelling. Eighty-one 
adults  were randomly divided into 2 treatment groups; who received 2 
infiltrations by using either 2 % lignocaine with 1:100,000 epinephrine buffered 
with 0.18 mL 8.4 % sodium bicarbonate or 2 % lignocaine with 1:100,000 
epinephrine. They stated that the addition of a sodium bicarbonate buffer to 2 % 
lignocaine with 1:100,000 epinephrine did not result in significantly decreased 
pain of infiltrations or significantly decreased pain of incision and drainage 
procedure when compared with 2 % lignocaine with 1:100,000 epinephrine. 
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Hashimoto S et al (2014)
32
 investigated the effect of epinephrine on 
pharmacokinetics of lignocaine and the pulpal blood volume after maxillary 
infiltration anesthesia in rats. Measured the 14C-radioactivity and 14C-
distribution in the maxilla and the dental pulp after the injection of 2 % 14C-
lignocaine with or without 10 mg/ mL epinephrine into the palatine mucosa 
proximal to the first molar. They found that lignocaine had infiltrated into the 
molar pulp after infiltration anesthesia. Furthermore they suggested that 
epinephrine augmented the retention of lignocaine in the pulp. 
Saatchi M et al (2015)
120
 compared the anaesthetic efficacy of buffered 
with non buffered 2 % lignocaine with 1:80,000 epinephrine solution for a 
inferior alveolar nerve block in patients with mandibular posterior teeth 
experiencing symptomatic irreversible pulpitis. Eighty adult patients were 
selected and they received 2 cartridges of either 2 % lignocaine with 1:80,000 
epinephrine buffered with 0.18 mL 8.4 % sodium bicarbonate or 2 % lignocaine 
with 1:80,000 epinephrine with 0.18 mL sterile distilled water using 
conventional inferior alveolar nerve  block injections. They concluded buffering 
the 2 % lignocaine + 1:80,000 epinephrine with 8.4 % sodium bicarbonate did 
not improve success of the inferior alveolar nerve block in mandibular molars in 
patients with symptomatic irreversible pulpitis. 
Schellenberg J et al (2015)
123
 determined the effect of 4 % buffered 
lignocaine on anaesthetic success of the inferior alveolar nerve block in patients 
having symptomatic irreversible pulpitis. One hundred patients were selected, 
and given inferior alveolar nerve block using either 2.8 mL 4 % lignocaine with 
1:100,000 epinephrine or 2.8 mL    4 % lignocaine with 1:100,000 epinephrine 
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buffered with sodium bicarbonate in a double-blind manner. They stated that for 
mandibular posterior teeth, a 4 % buffered lignocaine formulation did not result 
in a statistically significant increase in success rate or a decrease in injection 
pain of the inferior alveolar nerve block in patients with symptomatic 
irreversible pulpitis. 
Shetty KP et al (2015)
126
 compared the anaesthetic efficacy between the 
lignocaine with and without magnesium sulfate 50 % for inferior alveolar nerve 
blocks in patients with symptomatic irreversible Pulpitis. One hundred patients 
with symptomatic irreversible pulpitis of mandibular posterior teeth were 
selected randomly. They received 1 mL magnesium sulfate 50 % or distilled 
water 1 hour before administration of conventional inferior alveolar nerve block. 
They concluded that in mandibular posterior teeth diagnosed as symptomatic 
irreversible pulpitis, preoperative administration of 1 mL magnesium sulfate 50 
% resulted in statistically significant increase in the success of inferior alveolar 
nerve block compared with placebo. 
Fowler S et al (2015)
42
 determined the incidence of missed inferior 
alveolar nerve blocks by using a 1- or 2-cartridge volume of 2 % lignocaine with 
1:100,000 epinephrine in vital asymptomatic teeth and in emergency patients 
with the symptomatic irreversible pulpitis. Each subject received either a 1- or 
2-cartridge volume of 2 % lignocaine with 1:100,000 epinephrine.  They found 
that administration of a 2-cartridge volume was significantly better than a 1-
cartridge volume in both asymptomatic subjects and in emergency patients with 
irreversible pulpitis. 
REVIEW OF LITERATURE 
 
17 
 
Harreld TK (2015)
37
 compared the pain of infiltration and the pain of an 
incision and drainage procedure of a buffered versus a non buffered 4 % 
lignocaine formulation in symptomatic emergency patients presenting with a 
diagnosis of pulpal necrosis, associated periapical area, and acute clinical 
swelling. Eighty-eight patients were randomly divided into 2 groups; either 4 % 
lignocaine with 1:100,000 epinephrine buffered with 0.18 mL 8.4 % sodium 
bicarbonate using the buffering system or 4 % lignocaine with 1:100,000 
epinephrine. They concluded that buffering a 4 % lignocaine formulation did not 
significantly decrease the pain of infiltrations or significantly decrease the pain 
of incision and drainage procedure when compared with a non buffered 4 % 
lignocaine formulation in symptomatic patients with a diagnosis of pulpal 
necrosis and acute swelling.  
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ARTICAINE 
Winter et al (1972)
145
 compared maxillary infiltration 0f 1.0 ml 
articaine for lateral incisor to same volume of lignocaine and mepivacaine for 
anaesthetic efficacy in 39 patients and articaine in this study performed well 
compared to the other solutions. 
Haas et al (1990)
50
 compared articaine to prilocaine for both maxillary 
and mandibular buccal infiltration (1.5 ml ) of canine tooth. The two solutions 
provided similar success rates for pulpal anaesthesia after infiltration ( articaine 
65 % vs prilocaine 50 % ). 
Haas et al (1991)
51
 compared articaine to prilocaine for both maxillary 
and mandibular buccal infiltration (1.5 ml) of 2
nd
 molars. Articaine resulted in 
higher success rate in both arches, although difference were not statistically 
significant. 
Vahatalo et al (1993)
139
 compared articaine to lignocaine for maxillary 
lateral incisor infiltration (0.6 ml). All infiltrations resulted in successful pulpal 
anaesthesia, with no significant difference of onset or duration of the two 
solutions. 
Tofoli et al (2003)
135
 compared the anaeasthetic efficacy of articaine in 
association with 2 different concentration of epinephrine for IAN block. No 
significant difference in success, onset or duration between the two solutions 
were observed. 
Claffey et al (2004)
43
 compared articaine and lignocaine when 
administered via IAN block in patients experiencing IP in mandibular posterior 
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teeth. Success rates were 23 % for lignocaine and 24 % for articaine,  revealed 
no significant difference. Neither solution resulted in an acceptable rate of 
success for patients with IP. 
Elizabeth C et at ( 2004)
39
 compared anaesthetic efficacy of 4 % 
articaine with 1:100,000 epinephrine to 2 % lignocaine with 1:100,000 
epinephrine for inferior alveolar nerve blocks in patients having irreversible 
pulpitis in mandibular posterior teeth. Seventy-two emergency patients 
diagnosed with irreversible pulpitis of a mandibular posterior tooth randomly 
received anaesthesia in a double-blind manner.  They concluded there was no 
significant difference between the articaine and lignocaine solutions. Neither 
solution resulted in an acceptable rate of anaesthetic success in patients with 
irreversible pulpitis. 
Berlin J et al (2005)
45
 compared anaesthetic efficacy of intraligamentary 
injection of 4 % articaine with 1:100,000 epinephrine & 2 % lignocaine with 
1:100,000 epinephrine in mandibular posterior teeth. Using crossover design, 
intraligamentary injections of above solutions were injected using computer-
controlled local anaesthetics. They concluded efficacy of 4 % articaine with 
1:100,000 epinephrine was similar to the efficacy of 2 % lignocaine with 
1:100,000 epinephrine for intraligamentary injections. 
Berlin et al (2005)
11
 compared 1.4 ml of articaine and lignocaine when 
administered via computer controlled intraligamentary injections in mandibular 
posterior teeth . The success rates were 74 % for lignocaine and 86 % for 
articaine solutions. There was significant difference between the two solutions. 
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Mikesell et al (2005)
94
 compared articaine and lignocaine when 
administered via IAN block, testing molars, premolars and incisors. Lignocaine 
resulted in anaesthetic success ranging from 2-48 % while articaine resulted in a 
range 4-54 %. There was not significant difference between articaine and 
lignocaine solutions. 
Costa et al (2005)
32
 compared 1.8 ml of articaine and lignocaine for 
infiltration of maxillary posterior teeth . There was no significant difference 
between the success rate of articaine and lignocaine. Articaine did produce 
significantly shorter onset and longer duration of anaesthesia than lignocaine. 
Kanaa et al (2006)
67
 compared articaine and lignocaine in mandibular 
buccal infiltration of 1
st
 molar. Success rates were 65 % for articaine and 39 % 
for lignocaine, resulting in significantly more chance for anaesthetic with 
articaine. 
Rosenberg et al (2007)
119
 compared articaine and lignocaine buccal 
infiltration in mandibular posterior teeth with IP that requires supplemental 
anaesthesia. The mean percentage changes in VAS score was 70 % and 65 % for 
articaine and lignocaine respectively, demonstrating no significant difference. 
Jung et al (2008)
65
 compared buccal infiltration and IAN block for a 
standerd volume (1.7 ml) of articaine in mandibular 1
st
 molar. Success rate of 
buccal infiltration (54 %) and IAN block (43 %) were not found to be 
statistically significant, onset of infiltration was significantly faster in both the 
solutions. 
Evans et al (2008)
40
 compared articaine with lignocaine in maxillary 
infiltration of 1
st
 molar and lateral incisor. In maxillary lateral incisor articaine 
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exhibited a significantly higher success rates (88 %) when compared with 
lignocaine (62 %). Differences were not significant for first molar. 
Corbett et al (2008)
31
 compared articaine given by means of buccal or 
buccal and lingual infiltration to IAN block using lignocaine. Efficacy of 
articaine when given by infiltration was not statistically significant difference 
than using lignocaine via IAN block for mandibular 1
st
 molar 
Sherman et al (2008)
125
 compared articaine and lignocaine in patients 
with IP in either maxilla or mandibular posterior teeth. Overall anaesthetic 
success was 87.5 % in both arches. Articaine was as effective but not 
statistically superior to lignocaine. 
Haase et al (2008)
52
 compared articaine and lignocaine by mandibular 
1
st
 molar buccal infiltration after initial IAN block was given with articaine. 
Articaine resulted in a significantly higher success rate (88 %) than lignocaine 
(71 %) when given via buccal infiltration following an IAN block of articaine. 
Srinivasan et al (2009)
131
 compared articaine and lignocaine when 
delivered via buccal infiltration for maxillary posterior teeth diagnosed with IP. 
Success rate for articaine were 100 % for both 1
st
 molar and 1
st
 pre molar and for  
lignocaine were 30 % in first pre molar and 80 % in 1
st
 molar. There was a 
highly significant difference. 
Poorni S et al (2011)
108
 studied the anaesthetic efficacy of 4 % articaine 
with 1:100,000 epinephrine in inferior alveolar nerve block (IANB) and 
infiltration anaesthetic techniques to anesthetize mandibular molars with 
irreversible pulpitis. They stated that although Buccal Infiltartion and IANB of 4 
% articaine were equally effective, Buccal infiltration can be considered a viable 
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alternative in IANB for pulpal anesthesia in mandibular molars with irreversible 
pulpitis. 
Martin M et al ( 2011)
85
 conducted a prospective, randomized, single 
blind, crossover study comparing the degree of pulpal anesthesia with 1.8 mL 
and 3.6 mL of 4 % articaine with 1:100,000 epinephrine as a primary infiltration 
in the mandibular first molar. Eighty six asymptomatic adult subjects randomly 
received a primary mandibular buccal first molar infiltration of 1.8 mL or 3.6 
mL 4 % articaine with 1:100,000 epinephrine in two separate appointments. 
They concluded that the anaesthetic efficacy of 3.6 mL 4 % articaine with 
1:100,000 epinephrine is better than 1.8 mL of the same anaesthetic solution in a 
primary mandibular buccal infiltration of the first molar. However, the success 
rate of the 70 % is not high enough to support its use as a primary injection 
technique in the mandibular first molar.  
McEntire M et al (2011)
90
 Conducted a prospective, randomized, 
double-blind, crossover study comparing the degree of pulpal anesthesia 
obtained with 4 % articaine with 1:100,000 epinephrine and 4 % articaine with 
1:200,000 epinephrine as a primary infiltration in the mandibular first molar. 
They concluded the anaesthetic efficacy of 4 % articaine with 1:200,000 
epinephrine is comparable to 4 % articaine with 1:100,000 epinephrine in a 
primary mandibular buccal infiltration of the first molar. 
Kanaa MD et al (2012)
66
 compared the efficacy of supplementary 
repeat inferior alveolar nerve block with 2 % lignocaine & epinephrine, buccal 
infiltration with 4 % articaine with epinephrine, intraligamentary injection, or 
intraosseous injection after failed inferior alveolar nerve block for securing pain-
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free treatment in patients experiencing irreversible pulpitis in mandibular 
permanent teeth. Patients were received 2.0 mL of 2 % lignocaine with 1:80,000 
epinephrine as an IANB injection. They concluded inferior alveolar nerve block 
injection alone does not always allow pain-free treatment for mandibular teeth 
with irreversible pulpitis. Supplementary buccal infiltration with 4 % articaine 
with epinephrine and intraosseous injection with 2 % lidocaine with epinephrine 
are more likely to allow pain-free treatment than intraligamentary and repeat 
IANB injections with 2 % lidocaine with epinephrine for patients experiencing 
irreversible pulpitis in mandibular permanent teeth. 
Monteiro MR et al (2013)
95
 compared the anaesthetic efficacy of 
inferior alveolar nerve blocks with 1.8 mL of 2 % lignocaine to a buccal 
infiltration with 1.8 mL of 4 % articaine , both with 1 : 1,00,000 epinephrine, in 
patients with symptomatic irreversible pulpitis. They concluded that single 
anaesthesia techniques were not able to achieve pain-free emergency endodontic 
treatment, hence Supplemental anaesthetic techniques should be considered 
prior to the treatment procedures in order to increase  the success rate. 
Ahmad ZH et al (2014)
151
 determined the anaesthetic efficacy of 
inferior alveolar nerve  block using 4 % articaine and 2 % lignocaine 
supplemented with buccal infiltration. Fourty-five patients were selected and 
divided into three groups; group I with 2 % lignocaine + 1:2,00,000 epinephrine, 
group II with 2 % lignocaine + 1:80,000 epinephrine and group III with 4 % 
articaine + 1:1,00,000 epinephrine. They concluded that 4 % articaine can be 
used as effectively in obtaining profound anesthesia in patients with irreversible 
pulpitis. 
REVIEW OF LITERATURE 
 
24 
 
Singla M et al (2014)
130
 Compared anaesthetic efficacy of different 
volumes    (1.8 mL vs. 3.6 mL) of 4 % articaine with 1 : 1,00,000 epinephrine 
injected as buccal infiltrations after a failed inferior alveolar nerve block in 
patients with symptomatic irreversible pulpitis. Two hundred and thirty-four 
adult Patients were selected. They concluded that increasing the volume of 4 % 
articaine with 1 : 1,00,000 epinephrine from 1.8 to 3.6 mL, given as 
supplementary buccal infiltrations after a failed primary inferior alveolar nerve  
block with 1.8 mL of 4 % articaine with 1 : 1,00,000, did not improves the 
anaesthetic success rates in patients with symptomatic irreversible pulpitis. 
Rogers BS et al (2014)
118
 investigated the efficacy of 4 % articaine with 
2 % lignocaine for supplemental buccal infiltrations after an ineffective inferior 
alveolar nerve block in mandibular molars with irreversible pulpitis. In addition, 
the use of articaine for inferior alveolar nerve block and intraosseous injections 
was evaluated. They found Supplemental buccal infiltration with articaine was 
significantly more effective than lignocaine. The inferior alveolar success rate of 
4 % articaine is more as compared with 2 % lignocaine. 
Jason Kung et al (2015)
65
 concluded in his systemic review that the use 
of articaine for patients with symptomatic irreversible pulpitis showed a 
significant advantage to using articaine over lidocaine for supplementary 
infiltration after mandibular block anesthesia but no advantage when used for 
mandibular block anesthesia alone or for maxillary infiltration. 
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MATERIALS AND METHODS 
ARMAMENTARIUM ( Fig 1-4 & Fig 9 ) 
1. Mouth mirror, Explorer, Tweezer (GDC, Germany) 
2. Electric pulp vitality tester (API, Ashoosons, India)  
3. Electrolyte tooth paste (Thermoseal , ICPA Products)  
4. ROEKO Endo-Frost (Coltène/Whaledent Private Ltd, INDIA  
5. Aspirating syringe (Petite-Blue, Septodont, INDIA) 
6. 1 ml micro liter syringe ( DISPO VAN, Hindustan Syringes & Medical 
Devices Ltd, INDIA ) 
7. Septojet (27 G Long Needle, Septodont, INDIA) 
8. Sterile cotton, sterile gauze  
9. Rubber dam kit (GDC, Germany)  
10. Disposable gloves, Face Mask, Head Cap  
11. High speed Airotor hand piece (NSK,Tokyo, Japan)  
12. Endo Access kit (Dentsply, US) 
13. 10, 15, 20 H file (MANI, JAPAN)  
14. 10, 15, 20 K file (MANI, JAPAN) 
15. 3 % Sodium hypochlorite (Prime Dental product Private Ltd, INDIA) 
16. Lubricating paste ((R C Help, Prime Dental product Private Ltd, INDIA) 
17. Intra canal dressing paste (RCCal, Prime Dental product Private Ltd, INDIA)  
18. Temporary filling (Prime Dental product Private Ltd, INDIA) 
EXPERIMENTAL MATERIALS ( Fig 5-8 ) 
1. 2 % Lignocaine with 1: 80,000 Adrenaline (Lignospan Special, Septodont, 
INDIA) 
2. 4 % Articaine with 1:1,00,000 Adrenaline (Septanet, Septodont, INDIA) 
3. 8.4 % Sodium bicarbonate solution ( Micro fine chemicals, INDIA) 
4. 0.5 MOL/L Mannitol solution (Aculife healthcare Pvt. Ltd, INDIA ) 
MATERIALS AND METHODS 
 
26 
 
METHODOLOGY 
The study was carried out in the Department of Conservative Dentistry And 
Endodontics Tamilnadu Government Dental College And Hospital, Chennai, 
Tamilnadu, India.  
Study design  
Ethical clearance was obtained from the Institution’s Ethical Committee 
(Annexure I). 180 subjects who fulfilled the inclusion and exclusion criteria were 
chosen for the study with no discrimination based on sex, caste, religion or 
socioeconomic status.  
The complete treatment procedure was explained to the patients and a 
written informed consent was obtained from all the patients selected for the study. 
The 180 subjects were randomly divided into 6 groups of 30 subjects each.  
Blinding has been done by labeling the two local anaesthetic solutions as 
LA1 & LA2 and buffering agents as B1 & B2. The labeled materials were allocated 
to groups randomly as follow ( Fig 10-11 ) :   
1. Group I : LA2 
2. Group II : LA1 
3. Group III : LA2 + B1 
4. Group IV : LA1 + B1 
5. Group V : LA2 + B2 
6. Group VI : LA1 + B2 
Study protocol:  
1. Institutional ethical committee approval  
2. Obtaining  Thorough history, 
3. Thorough Clinical Examination including diagnosis, 
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4. Radiographic evaluation of selected region using intra oral periapical 
radiograph (IOPA) considering patient safety guidelines during radiographic 
exposure with lead apron and thyroid collar  for the patient and thermal 
tests(TT) to confirm diagnosis, 
5. Informed consent from the patient, 
6. Patients allotted randomly to the respective group as Sequence generated by 
computerized permutted block. 
7. Preparing the buffered anaesthetic solution for nerve block(IANB), 
8. Pain assessment by Heft-parker visual analogue scale on the pain on 
injection, access opening and endodontic instrumentation.  
9. Post operative instructions 
 
CRITERIA FOR SELECTION 
Inclusion Criteria: 
1. Between the age of 18-65 years 
2. In good health (ASA classification class I) 
3. able to provide informed consent  
4. Dental Caries mandibular molars with diagnosis of symptomatic irreversible 
pulpitis 
Exclusion criteria: 
1. Allergies to local anaesthetics or sulfites 
2. Allergies to mannitol 
3. Bellow the age of 18 years 
4. History of significant medical conditions(ASA Class II or higher) 
5. Taking any medication, which may affect the pain assessment 
6. Active pathosis at the site of injection 
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7. Inability to give informed concent 
Methodology of examination: 
Thorough History and Clinical Examination for an accurate diagnosis of 
symptomatic irreversible pulpitis with electric pulp test (EPT) (Fig 16), thermal test 
(cold test) (Fig 17), then Radiological Examination (IOPA) to confirm diagnosis and 
to rule out any other pathology. 
 
DATA COLLECTION & METHODS 
Clinical parameters: 
Pain assessment : Heft -Parker Visual Analogue Scale 
Observed clinical parameters: Pain assessment on pain on injection, access 
opening and endodontic instrumentation. 
 
 
 
Radiological parameters: 
IOPA to confirm diagnosis and to rule out any other pathology. 
Buffering agents used in the study (Fig 11): 
1. 8.4 % of Sodium Bicarbonate is commercially available in 50mEq/vial 
(McGUFF Company, Inc). 
2. 0.5 mol/L mannitol is prepared from commercially available 20% mannitol 
solution (Baxter India)  in the department of biochemistry, Madras Medical 
College, Chennai. 
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RANDOMIZATION 
Sequence generation:  
Sequence generated by computerized permutted block randomization with 
block size 6 for each set. 
Allocation concealment mechanism (Fig 12):  
Allocation concealment done to protect the randomization process so that the 
treatment to be carried out is not known before the patient is entered into the study. 
Silver colour opaque envelops are used to keep the randomization details and the 
prepared local anaesthetic to be injected for the allotted patient. 
Blinding (Fig 10-11): 
This study done with triple blinding. The one preparing the anaesthetic 
solution was blinded as they are unaware of the fact that which group is going to 
receive the prepared solutions, participants and operator were blinded since both 
were not knowing the solution injecting or receiving respectively . Those assessing 
outcomes are blinded since they were not knowing to which group the patient 
belongs to or which solution they have received. 
OPERATIVE PROCEDURE: 
Before starting any operative procedure, test dose (fig 18,19) of local 
anaesthetic solution and buffered solutions will be given for all the participants to 
check for allergy to any material. In case of any complication, the materials for 
management of allergy were kept ready (fig 23). 
Preparing the buffered solutions (Fig 13-15): 
The buffered local anaesthetic solution should be freshly prepared before 
injecting, is prepared in the following manner: 
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1. Drawing the 3ml of local anaesthetic solution from 30ml vial of 2 % 
lignocaine and replacing the drawn solution by 3ml 0f 8.4 % sodium 
bicarbonate or 3 ml of 0.5 mol/L mannitol 
2. Drawing the 6ml of local anaesthetic solution from 30ml vial of 4 % 
articaine and 6ml of 8.4 % sodium bicarbonate or 6ml of 0.5 mol/L mannitol 
(since we are using 4 % articaine which is double the concentration 
compared to 2 % lignocaine).  
3. The prepared buffered solution is mixed well before injection. 
4. The prepared local anaesthetic solution injected using conventional IANB to 
the patient allotted to respective group (Fig 20).  
5. Access opening done under rubber dam isolation (Fig 21). 
6. Instrumentation done upto 20 size K file till the measured working length 
(Fig 22).   
Group I: LA2 
1. Draping the Patient 
2. Preparing the solutions to inject for inferior alveolar nerve block 
3. Marking of Landmarks for Needle penetration and injection of solution 
for inferior alveolar nerve block  
4. Completion of nerve block and assessment of pain for the following 
a. Pain on injection 
b. Pain on access opening and cavity preparation 
c. Pain on endodontic instrumentation 
5. Post operative instructions 
Group II: LA1 
1. Draping the Patient 
2. Preparing the solutions to inject for inferior alveolar nerve block 
MATERIALS AND METHODS 
 
31 
 
3. Marking of Landmarks for Needle penetration and injection of solution 
for inferior alveolar nerve block  
4. Completion of nerve block and assessment of pain for the following 
a. Pain on injection 
b. Pain on access opening and cavity preparation 
c. Pain on endodontic instrumentation 
5. Post operative instruction 
Group III: LA2 + B1 
1. Draping the Patient 
2. Preparing the solutions to inject for inferior alveolar nerve block 
3. Marking of Landmarks for Needle penetration and injection of solution 
for inferior alveolar nerve block  
4. Completion of nerve block and assessment of pain for the following 
a. Pain on injection 
b. Pain on access opening and cavity preparation 
c. Pain on endodontic instrumentation 
5. Post operative instruction 
Group IV: LA1 + B1 
1. Draping the Patient 
2. Preparing the solutions to inject for inferior alveolar nerve block 
3. Marking of Landmarks for Needle penetration and injection of solution 
for inferior alveolar nerve block  
4. Completion of nerve block and assessment of pain for the following 
a. Pain on injection 
b. Pain on access opening and cavity preparation 
c. Pain on endodontic instrumentation 
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5. Post operative instruction 
Group V: LA2 + B2 
1. Draping the Patient 
2. Preparing the solutions to inject for inferior alveolar nerve block 
3. Marking of Landmarks for Needle penetration and injection of solution 
for inferior alveolar nerve block  
4. Completion of nerve block and assessment of pain for the following 
a. Pain on injection 
b. Pain on access opening and cavity preparation 
c. Pain on endodontic instrumentation 
5. Post operative instruction 
Group VI : LA1 + B2 
1. Draping the Patient 
2. Preparing the solutions to inject for inferior alveolar nerve block 
3. Marking of Landmarks for Needle penetration and injection of solution 
for inferior alveolar nerve block  
4. Completion of nerve block and assessment of pain for the following 
a. Pain on injection 
b. Pain on access opening and cavity preparation 
c. Pain on endodontic instrumentation 
5. Post operative instruction 
 
Evaluation intervals: 
Pre operative pain was measured before starting the endodontic procedure as 
base line data and Pain on injection, pain on endodontic access cavity preparation & 
pain on endodontic instrumentation were evaluated. 
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Post operative follow up:  
The patients were reviewed immediatly after the operative procedure for the 
Pain on injection, pain on endodontic access cavity preparation and pain on 
endodontic instrumentation to record the values on Heft Parker Visual Analog Scale.  
The following data were obtained:  
1. Pain on injection 
2. Pain on endodontic access opening 
3. Pain on instrumentation 
All data obtained were tabulated and analysed statistically using statistical software 
SPSS version 22. 
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PROCEDURAL FLOW CHART 
 
 
 
 
 
 
180 PATIENTS ASSESSED FOR ELIGIBILITY ACCORDING TO INCLUSION AND 
EXCLUSION CRITERIA 
PREPARING THE SOLUTIONS TO INJECT FOR INFERIOR ALVEOLAR NERVE BLOCK 
 
MARKING THE LANDMARKS FOR NEEDLE PENETRATION AND INJECTION OF 
SOLUTION FOR INFERIOR ALVEOLAR NERVE BLOCK 
 
COMPLETION OF INFERIOR ALVEOLAR  NERVE BLOCK 
RUBBER DAM ISOLATION 
ACCESS CAVITY PREPARATION 
RANDOMISED 
ALLOCATED TO INTERVENTION 
GROUP I 
INSTRUMENTATION 
DOCUMENTATION OF VALUES USING HEFT PARKER VISUAL 
ANALOG SCALE AFTER EACH CLINICAL PROCEDURE 
GROUP II GROUP III GROUP IV GROUP V GROUP VI 
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MATERIALS  
               
 
  
Fig 1. DIAGNOSTIC INSTRUMENT KIT                          Fig 2. LOCAL ANAESTHESIA 
INJECTION KIT 
 
Fig 3. ACCESS OPENING KIT Fig 4. INTRUMENTATION KIT 
Fig 5. 8.4% SODIUM BICARBONATE Fig 6. 0.5MOL/L MANNITOL 
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Fig 8. 4% ARTICAINE + 1:1,00,000 
EPINEPHRINE 
Fig 7. 2% LIGNOCAINE + 1:80,000 
EPINEPHRINE 
 
Fig 9. MATERIAS USED FOR  ACESS AND 
BIOMECHANICAL PREPARATION 
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LABELLING MATERIAL FOR RANDOMIZATION AND CONCEALMENT 
 
 
 
 
 
 
 
 
  
Fig 11. LABELLED BUFFERING AGENTS 
Fig 12. ALLOCATION CONCEALMENT 
 
Fig 10. LABELLED LOCAL ANAESTHETIC 
SOLUTIONS 
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PREPARING THE BUFFERED LOCAL ANAESTHETIC SOLUTION 
 
 
 
 
 
 
 
 
  
Fig 15. REPLACING THE DRAWN 
LOCAL ANAESTHESIA BY 
BUFFERING AGENT 
 
Fig 14. WITHDRAW 0.18 ML OF 
BUFFERING AGENT 
 
Fig 13. WITHDRAW 0.18 ML OF 
LOCAL ANAESTHESIA 
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OPERATIVE PROCEDURE 
              
 
 
            
 
 
 
 
 
Fig 16. PULP VITALITY USING EPT 
 
Fig 18. TEST DOSE 
 
Fig 17. PULP VITALITY USING COLD 
SPRAY 
 
Fig 20. LOCAL ANAESTHETIC 
INJECTION 
 
Fig 19. MARKING OF AREA AFTER TEST DOSE 
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MATERIAL FOR COMPLICATION MANAGEMENT 
 
 
Fig 23. ADRENALINE AND 
HYDROCARTISONE 
 
Fig 22. WORKING LENGTH 
MEASURED FOR 
INSTRUMENTATION  
 
Fig 21. ACCESS OPENING 
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RESULTS 
One hundred eighty adult patients participated in this study. All were 
emergency patients reported to Tamil Nadu Government Dental College And 
Hospital, Chennai-03. All the participants were selected following the established 
inclusion and exclusion criteria for this study. 
Values of Pre operative pain was measured before starting the endodontic 
procedure as base line data and Pain on injection, pain on endodontic access cavity 
preparation & pain on endodontic instrumentation was evaluated after completion of 
endodontic procedure were tabulated. None of the patients presented with allergy to 
any material in the study. 
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PARTICIP
ANT 
SERIAL 
NUMBER 
 
PRE OPERATIVE PAIN( MM) 
GROUP I GROUP II GROUP III GROUP IV GROUP V GROUP VI 
01 170 123 93 160 124 143 
02 170 95 153 137 89 133 
03 138 113 97 142 120 137 
04 126 157 53 90 105 145 
05 140 123 123 103 145 50 
06 157 143 143 105 50 126 
07 123 156 156 145 126 140 
08 143 142 142 50 140 133 
09 156 90 90 126 133 166 
10 142 103 103 140 166 88 
11 90 105 105 133 88 143 
12 103 145 145 166 143 156 
13 105 50 50 88 156 105 
14 145 126 126 143 105 145 
15 50 140 140 156 145 143 
16 126 133 133 105 50 133 
17 140 166 166 145 126 137 
18 133 88 88 50 140 145 
19 166 143 143 126 133 50 
20 88 156 156 140 145 126 
21 143 142 142 133 50 140 
22 156 123 123 166 126 133 
23 142 95 95 88 140 166 
24 90 113 113 143 133 88 
25 103 157 157 156 166 143 
26 105 123 123 142 88 156 
27 144 143 143 123 143 105 
28 170 156 156 140 156 156 
29 126 142 142 133 105 105 
30 140 90 90 166 145 145 
TABLE 01: Base line values of preoperative pain using Heft Parker Visual Analog Scale 
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PARTICIPANT 
SERIAL 
NUMBER 
 
PAIN ON 
INJECTION(MM) 
 
PAIN ON ENDODONTIC 
ACCESS OPENING(MM) 
 
PAIN ON ENDODONTIC 
INSTRUMENTATION(MM) 
01 43 140 55 
02 50 103 170 
03 66 126 126 
04 78 140 140 
05 30 157 157 
06 58 123 123 
07 95 143 143 
08 140 84 22 
09 44 45 30 
10 75 120 58 
11 28 134 95 
12 16 163 140 
13 30 58 103 
14 22 95 105 
15 30 140 145 
16 58 44 50 
17 95 75 126 
18 140 126 140 
19 44 140 157 
20 75 157 123 
21 88 123 143 
22 143 143 22 
23 156 84 30 
24 142 45 58 
25 90 120 95 
26 140 140 140 
27 44 44 103 
28 75 75 105 
29 88 126 145 
30 143 140 50 
TABLE 02: Group I Values measured using Heft Parker Visual Analog Scale for 
observed clinical parameters 
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PARTICIPANT 
SERIAL 
NUMBER 
 
PAIN ON 
INJECTION(MM) 
 
PAIN ON ENDODONTIC 
ACCESS OPENING(MM) 
 
PAIN ON ENDODONTIC 
INSTRUMENTATION(MM) 
01 71 118 160 
02 0 0 0 
03 13 135 55 
04 58 84 157 
05 95 45 123 
06 140 120 143 
07 44 134 22 
08 75 163 30 
09 28 58 58 
10 16 95 95 
11 30 140 140 
12 22 44 103 
13 30 75 105 
14 95 135 145 
15 140 84 160 
16 44 45 0 
17 75 120 125 
18 28 134 157 
19 16 163 123 
20 30 58 143 
21 22 95 22 
22 16 90 30 
23 30 103 58 
24 22 105 95 
25 30 145 140 
26 95 50 103 
27 140 126 105 
28 44 22 145 
29 66 30 160 
30 78 95 170 
TABLE 03: Group II Values measured using Heft Parker Visual Analog Scale for observed 
clinical parameters 
RESULTS 
 
39 
 
 
 
 
PARTICIPANT 
SERIAL 
NUMBER 
 
PAIN ON 
INJECTION(MM) 
 
PAIN ON ENDODONTIC 
ACCESS OPENING(MM) 
 
PAIN ON ENDODONTIC 
INSTRUMENTATION(MM) 
01 54 40 07 
02 90 63 61 
03 65 0 12 
04 50 05 07 
05 102 35 39 
06 66 63 122 
07 83 0 63 
08 95 27 13 
09 62 93 84 
10 39 123 74 
11 122 47 65 
12 63 05 50 
13 13 35 102 
14 84 63 66 
15 74 0 83 
16 65 27 95 
17 50 93 90 
18 102 62 103 
19 66 39 105 
20 83 122 145 
21 95 63 50 
22 62 13 126 
23 39 84 65 
24 122 66 50 
25 74 83 102 
26 65 95 66 
27 50 62 83 
28 102 39 95 
29 66 122 133 
30 83 74 111 
TABLE 04: Group III Values measured using Heft Parker Visual Analog Scale for observed 
clinical parameters 
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PARTICIPANT 
SERIAL 
NUMBER 
 
PAIN ON 
INJECTION(MM) 
 
PAIN ON ENDODONTIC 
ACCESS OPENING(MM) 
 
PAIN ON ENDODONTIC 
INSTRUMENTATION(MM) 
01 0 0 27 
02 15 17 41 
03 44 73 28 
04 38 12 36 
05 22 28 73 
06 73 36 10 
07 12 73 26 
08 28 10 84 
09 36 26 93 
10 73 122 133 
11 10 63 10 
12 26 13 26 
13 84 84 84 
14 93 66 22 
15 133 28 73 
16 73 36 12 
17 83 73 28 
18 165 10 36 
19 28 26 73 
20 28 122 10 
21 36 63 26 
22 73 13 84 
23 10 84 26 
24 26 84 84 
25 84 74 22 
26 93 65 73 
27 133 50 12 
28 10 102 28 
29 26 66 36 
30 84 83 73 
TABLE 05: Group IV Values measured using Heft Parker Visual Analog Scale for observed 
clinical parameters 
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PARTICIPANT 
SERIAL 
NUMBER 
 
PAIN ON 
INJECTION(MM) 
 
PAIN ON ENDODONTIC 
ACCESS OPENING(MM) 
 
PAIN ON ENDODONTIC 
INSTRUMENTATION(MM) 
01 20 25 30 
02 123 70 95 
03 67 0 17 
04 122 84 66 
05 63 93 83 
06 13 133 95 
07 84 73 62 
08 74 83 39 
09 65 165 122 
10 50 28 63 
11 102 28 13 
12 66 36 30 
13 83 73 95 
14 95 10 17 
15 62 28 66 
16 39 28 83 
17 122 36 95 
18 74 95 62 
19 65 62 39 
20 50 39 122 
21 102 122 73 
22 66 74 10 
23 83 65 28 
24 95 66 28 
25 62 83 36 
26 39 95 95 
27 122 62 165 
28 74 39 28 
29 135 122 28 
30 153 133 36 
TABLE 06: Group V Values measured using Heft Parker Visual Analog Scale for 
observed clinical parameters 
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PARTICIPANT 
SERIAL 
NUMBER 
 
PAIN ON 
INJECTION(MM) 
 
PAIN ON ENDODONTIC 
ACCESS OPENING(MM) 
 
PAIN ON ENDODONTIC 
INSTRUMENTATION(MM) 
01 03 71 07 
02 15 17 21 
03 93 85 70 
04 73 36 05 
05 10 73 35 
06 26 10 63 
07 84 26 0 
08 93 84 27 
09 133 93 93 
10 73 133 62 
11 83 10 39 
12 165 26 122 
13 28 84 63 
14 28 22 13 
15 36 73 84 
16 73 12 66 
17 10 28 83 
18 28 36 95 
19 28 73 62 
20 36 122 39 
21 95 63 122 
22 62 13 36 
23 39 84 73 
24 122 84 10 
25 74 74 28 
26 65 65 28 
27 03 50 36 
28 15 102 95 
29 93 66 33 
30 73 83 110 
TABLE 07: Group VI Values measured using Heft Parker Visual Analog Scale for 
observed clinical parameters 
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BASE LINE DATA 
The mean and standard deviation values and results of ANOVA & Tukeys Post Hoc 
tests  were obtained  for pre operative pain are presented in Table 8 to 10 
 
 
 
 
 
 
OBSERVED 
CLINICAL 
PARAMETER 
 
GROUPS 
 
I 
 
II 
 
III 
 
IV 
 
V 
 
VI 
 
MEA
N 
 
SD 
 
 
MEA
N 
 
SD 
 
 
ME
AN 
 
SD 
 
 
MEA
N 
 
SD 
 
 
MEA
N 
 
SD 
 
 
MEA
N 
 
SD 
 
PRE 
OPERATIVE 
PAIN 
 
131.
00 
 
28.6 
 
126.0
3 
 
27.2 
 
122
.97 
 
30.5 
 
128.0
0 
 
30.7 
 
122.0
7 
 
32.3 
 
129.3
7 
 
29.2 
 
 
 
 
 
 
 
 
OBSERVED CLINICAL PARAMETER Significance between 
groups 
PRE OPERATIVE PAIN 0.856 
 
 
 
 
 
 
 
Table 8: Mean And Standard Deviation of preoperative pain for Group I, II, 
III, IV, V & VI. 
 
Table 9: ONE WAY ANOVA analysis for preoperative pain values for Group 
I, II, III, IV, V & VI  
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(I)GROUP 
 
(J)GROUP 
 
PRE OPERATIVE PAIN 
 
 
1 
2 .987 
3 .903 
4 .999 
5 .890 
6 1.000 
 
 
2 
1 .987 
3 .999 
4 1.000 
5 .998 
6 .998 
 
 
3 
1 .903 
2 .999 
4 .987 
5 1.000 
6 .962 
 
 
4 
1 .999 
2 1.000 
3 .987 
5 .983 
6 1.000 
 
 
5 
1 .890 
2 .998 
3 1.000 
4 .983 
6 .954 
 
 
6 
1 1.000 
2 .998 
3 .962 
4 1.000 
5 .954 
Table 10: Tukey Post Hoc Test results of preoperative pain values for Group I, 
II, III, IV, V & VI. 
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The dependant variables in our study were: 
1. Pain on injection 
2. Pain on endodontic access opening 
3. Pain on instrumentation 
The independent variables analyzed were 6 different materials and at various 
intervals of time corresponding to the procedures 
The quantitative data obtained were subject to the following statistical analysis: 
 Descriptive Statistics for mean and standard deviation. 
 One Way Analysis of Variance for Intergroup analysis. 
 Tukey Post Hoc Test for Pairwise comparison.  
 
The p value of  less than 0.05 (p<0.05) was considered significant in our study.  
 
The mean and standard deviation values and results of ANOVA & Tukeys Post Hoc 
tests  were obtained  for observed clinical parameters are presented in Table 11 to 13 
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OBSERVED 
CLINICAL 
PARAMETERS 
 
GROUPS 
 
I 
 
II 
 
III 
 
IV 
 
V 
 
VI 
 
MEA
N 
 
SD 
 
 
MEA
N 
 
SD 
 
 
ME
AN 
 
SD 
 
 
MEA
N 
 
SD 
 
 
MEA
N 
 
SD 
 
 
MEA
N 
 
SD 
 
PAIN ON 
INJECTION 
 
77.53 
 
43.1 
 
53.1 
 
39.6 
 
72.
8 
 
24.5 
 
54.6 
 
42.0 
 
79.0 
 
33.3 
 
58.6 
 
41.1 
PAIN ON 
ACCESS 
OPENING 
 
111.7
7 
 
37.8 
 
93.7 
 
43.3 
 
54.
7 
 
36.9 
 
53.4 
 
34.2 
 
68.3 
 
40.0 
 
59.9 
 
34.1 
PAIN ON 
INSTRUMENTA
TION 
 
103.3 
 
45.5 
 
105.9 
 
50.5 
 
95.
5 
 
36.9 
 
46.3 
 
32.0 
 
60.7 
 
38.2 
 
54.0 
 
35.3 
 
 
 
 
 
OBSERVED CLINICAL PARAMETERS Significance between 
groups 
PAIN ON INJECTION 0.015 
PAIN ON ACCESS OPENING 0.000 
PAIN ON INSTRUMENTATION 0.000 
 
 
 
 
Table 11:  DISCRIPTIVE RESULTS for Observed Clinical Parameters  Of  
Group I, II, III, IV, V & VI in their Mean And Standard Deviation Values. 
 
Table 12:  ONE WAY ANOVA for Observed Clinical Parameters  Of  Group 
I, II, III, IV, V & VI in their P Values. 
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(I)GROUP 
 
(J)GROUP 
 
PAIN ON 
INJECTION 
 
PAIN ON 
ACCESS 
OPENING 
 
PAIN ON INSTRUMENTATION 
 
 
1 
2 .130 .437 1.000 
3 .997 .000 .096 
4 .183 .000 .000 
5 1.000 .000 .001 
6 .386 .000 .000 
 
 
2 
1 .130 .437 1.000 
3 .335 .001 .118 
4 1.000 .001 .000 
5 .091 .103 .002 
6 .993 .009 .000 
 
 
3 
1 .997 .000 .096 
2 .335 .001 .118 
4 .428 1.000 .067 
5 .989 .734 .722 
6 .693 .995 .322 
 
 
4 
1 .183 .000 .000 
2 1.000 .001 .000 
3 .428 1.000 .067 
5 .132 .646 .748 
6 .999 .985 .978 
 
 
5 
1 1.000 .000 .001 
2 .091 .103 .002 
3 .989 .734 .722 
4 .132 .646 .748 
6 .301 .955 .988 
 
 
6 
1 .386 .000 .000 
2 .993 .009 .000 
3 .693 .995 .322 
4 .999 .985 .978 
5 
.301 
.955 .988 
Table 13:  Tukey Post Hoc Test  results for Observed Clinical Parameters  Of  
Group I, II, III, IV, V & VI in their P Values. 
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Graphical representation of results 
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GRAPH 01: COMPARISON OF PREOPERATIVE VALUES  
 
GRAPH 02: COMPARISON OF PAIN ON INJECTION VALUES  
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GRAPH 03: COMPARISON OF PAIN ON ACCESS OPENING VALUES  
 
GRAPH 04: COMPARISON OF PAIN ON INSTUMENTATION VALUES  
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INFERENCE 
Initial preoperative pain 
Base line values of preoperative pain measured on Heft Parker visual analog 
scale for group I, II, III, IV, V, VI are tabulated in table 01. The mean and standard 
deviation for base line values of group I, II, III, IV, V, VI were 131.00±28.6, 
126.03±27.2, 122.97±30.5, 128.00±30.7, 122.07±32.3, 129.37±29.2 respectively. 
Analyzing the data on ANOVA showed no significant difference between the 
groups with the P value 0.856. Tukeys post hoc results confirmed that there is 
significant difference among the groups. 
 
Pain on injection 
Pain on injection values measured on Heft Parker visual analog scale for 
group I, II, III, IV, V, VI are tabulated in table 02-07. The mean and standard 
deviation values of group I, II, III, IV, V, VI were 77.53±43.1, 53.1±39.6, 
72.8±24.5, 54.6±42.0, 79.0±33.3, 58.6±41.1 respectively. Analyzing the data on 
ANOVA showed significant difference between the groups with the P value 0.015. 
Tukeys post hoc test failed to show the significant difference among the groups. 
 
Pain on access opening 
Pain on access opening values measured on Heft Parker visual analog scale 
for group I, II, III, IV, V, VI are tabulated in table 02-07. The mean and standard 
deviation values of group I, II, III, IV, V, VI were 111.77±37.8, 93.7±43.3, 
54.7±36.9, 53.4±34.2, 68.3±40.0, 59.9±34.1 respectively. Analyzing the data on 
ANOVA showed highly significant difference between the groups with the P value 
RESULTS 
 
51 
 
0.000. Tukeys post hoc results showed that there is significant difference among 
various groups as follow:  
 Group I showed significant difference between group III, IV, V & VI 
with P value 0.000, 0.000, 0.000 & 0.000 respectively and no significant 
difference with group II (0.437). 
 Group II showed significant difference between group III, IV & VI with 
P value 0.001, 0.001 & 0.009 respectively and no significant difference 
with group I & V (0.437 & 0.103). 
 Group III showed significant difference between group I & II with P 
value 0.000 & 0.001 respectively and no significant difference between 
group IV, V & VI (1.000, 0.734 & 0.995). 
 Group IV showed significant difference between group I & II with P 
value 0.000 & 0.001 respectively and no significant difference with 
group III, V & VI (1.000, 0.646 & 0.985). 
 Group V showed significant difference between group I with P value 
0.000 and no significant difference between group II, III, IV & VI 
(0.103, 0.734, 0.646 & 0.955). 
 Group VI showed significant difference between group I & II with P 
value 0.000 & 0.000 respectively and no significant difference between 
group III, IV & V (0.995, 0.985 & 0.955). 
IV<III<VI<V<II<I 
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Pain on Instrumentation 
Pain on instrumentation values measured on Heft Parker visual analog scale 
for group I, II, III, IV, V, VI are tabulated in table 02-07. The mean and standard 
deviation values of group I, II, III, IV, V, VI were 103.3±45.5, 105.9±50.5, 
95.5±36.9, 46.3±32.0, 60.7±38.2, 54.0±35.3 respectively showed variable difference 
in their numbers. Analyzing the data on ANOVA showed highly significant 
difference between the groups with the P value 0.000. tukeys post hoc results 
showed that there is significant difference among various groups as follow: 
 
 Group I showed significant difference between group IV, V, VI with P value 
0.000, 0.001, 0.000 respectively and no significant difference with group II 
& III with (1.000 & 0.096). 
 Group II showed significant difference between group IV, V, VI with P 
value 0.000, 0.002, 0.000 respectively and no significant difference with 
group I & III (1.000 & 0.118). 
 Group III showed no significant difference with group I, II, IV, V, VI (0.096, 
0.118, 0.067, 0.722 & 0.322). 
 Group IV showed significant difference between group I, II with P value 
0.000, 0.000 respectively and no significant difference with group III, V & 
VI (0.067, 0.748 & 0.978). 
 Group V showed significant difference between group I & II with P value 
0.001 & 0.002 respectivly and no significant difference with group III, IV & 
VI (0.722, 0.748 & 0.988). 
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 Group VI showed significant difference between group I, II with P value 
0.000, 0.000 respectively and no significant difference with group III, IV & 
V (0.322, 0.978 & 0.988). 
IV<VI<V<III<I<II 
Decoding of labeled materials for blinding 
 
1. LA1: 4 % ARTICAINE WITH 1:1,00,000 EPINEPHRINE 
2. LA2: 2 % LIGNOCAINE WITH 1:80,000 EPINEPHRINE 
3. B1: 0.5 MOL/L MANNITOL 
4. B2: 8.4 % SODIUM BICARBONATE 
 
Distribution of materials to respective groups 
 
1. GROUP I     : 2% LIGNOCAINE WITH 1:80,000 EPINEPHRINE 
2. GROUP II    : 4% ARTICAINE WITH 1:1,00,000 EPINEPHRINE 
3. GROUP III  : 2% LIGNOCAINE WITH 1:80,000 EPINEPHRINE +       
0.5 MOL/L MANNITOL 
4. GROUP IV  : 4 % ARTICAINE WITH 1:1,00,000 EPINEPHRINE +       
0.5 MOL/L MANNITOL 
5. GROUP V    : 2 % LIGNOCAINE WITH 1:80,000 EPINEPHRINE + 8.4 % 
SODIUM BICARBONATE 
6. GROUP VI  : 4 % ARTICAINE WITH 1:1,00,000 EPINEPHRINE + 8.4 % 
SODIUM BICARBONATE 
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DISCUSSION 
Local anesthetics exert their pharmacologic actions on the nerve membrane. 
Many theories have tried to explain the mechanism of action of local anesthetics. 
The specific receptor theory is the most accepted theory today. This theory holds 
that local anesthetics bind to specific receptors within the sodium channel which 
results in decreased or eliminated sodium permeability
82
. Local anesthetics bind the 
helical segments of sodium channels. Once bound, the sodium channels restrict 
movement of sodium across the membrane and keep sodium channels in an inactive 
configuration. The result is an ultimate failure of action potential and propagation 
down the neuron.  
Local anesthetics are said to produce a use-dependent block. This concept 
suggests that local anesthetics are particularly effective in blocking high frequency 
nerve impulses because local anesthetics are better able to reach their site of action 
within the sodium channel during a channel’s inactive state following 
depolarization. If a nerve is rapidly firing, the channels will be active more 
frequently increasing the opportunity for local anesthetic to reach the site of action, 
resulting in a use-dependent blockade of nerve impulse
2
. 
Pulpitis in human dentition can be described as a diseased state of teeth 
caused by any insult that disrupts the healthy pulp. This pathology can cause 
intermittent or spontaneous pain. Teeth in this state can respond differently to 
stimuli that would be considered normal. This is referred to as hypersensitivity or 
allodynia
56
. An extremely cold stimulus can be very helpful in the diagnosis of 
pulpitis. Pressure, heat, and especially cold sensations can be exaggerated and/or 
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prolonged. When pulpal disease has progressed to a state in that the body’s normal 
immune response is unable to repair the damage from this disease, a diagnosis of 
irreversible pulpitis is made. The presence of pulpitis can be of significance when 
administering an IAN block. Lack of success of the IAN block can be due to 
possible heightened or hypersensitivity of the tooth
61
. 
Clinical studies in patients with symptomatic irreversible pulpitis have found 
success with the IANB occurred between 15-57 % of the time
111
. These studies 
would indicate that anesthesia is often difficult to achieve in symptomatic 
irreversible pulpitis.  Claffey et al
25
. compared the anesthetic efficacy of 4 % 
articaine with 1:100,000 epinephrine to 2 % lidocaine with 1:100,000 epinephrine 
for inferior alveolar nerve blocks in patients experiencing irreversible pulpitis in 
mandibular posterior teeth. The success rate for the IANB using articaine was 24 % 
and for lidocaine 23 %. They found no significant difference between the articaine 
and lidocaine solutions. Tortamano et al
136
. also found that articaine and lidocaine 
had no significant difference in anesthetic success of the inferior alveolar nerve 
block and that neither solution resulted in a successful rate of anesthesia in posterior 
mandibular teeth. Sherman et al
125
. compared 4 % articaine with 1:100,000 
epinephrine with 2 % lidocaine with 1:100,000 epinephrine for Gow-Gates blocks in 
patients experiencing symptomatic irrerversible pulpitis. No difference between the 
2 anesthetics was found Aggarwal et al
2
. studied pretreatment medication with 
nonsteroidal anti-inflammatory drugs. Placebo gave 29 % success rate. 
Premedication with ketorolac gave 39 % success and ibuprofen gave 27 % success. 
There was no significant difference between the 3 groups in patients with 
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symptomatic irreversible pulpitis in mandibular posterior teeth. Oleson et al
102
. also 
studied the effect of preoperative ibuprofen on the success of the inferior alveolar 
nerve block in patients with irreversible pulpitis. The success rate for the IANB was 
41 % with preoperative ibuprofen and 35 % with placebo with no significant 
difference between the 2 groups. 
Hannan et al
55
  noted that accurate placement of the needle via ultrasound 
technology also does not result in more successful pulpal anesthesia, showing that 
the accuracy of needle placement is not a primary reason for pulpal anesthetic 
failure in the mandible. Berns and sadow
12 
 researched radiographic methods to 
locate the mandibular foramen, to help give an accurate injection, but discovered it 
did not increase the rate of anesthetic success. Simon et al
128
 studied accurate 
placement of solution deposition to the inferior alveolar nerve via a peripheral nerve 
stimulator and showed no increase in success rate of pulpal anesthesia when 
compared with a conventional inferior alveolar nerve block.  
Accessory innervation via the mylohyoid nerve is hypothesized to contribute 
to inferior alveolar nerve block failure, specifically regarding pulpal anesthesia of 
the first mandibular molar
127
 However, Clark et al
26
 showed that a combination of 
inferior alveolar nerve block and mylohyoid nerve block did not improve pulpal 
anesthesia, nor does a mylohyoid nerve block predictably ensure pulpal anesthesia 
in mandibular teeth.  
McCartney et al
89
 studied the pain associated with needle insertion, 
placement, and solution deposition for the conventional inferior alveolar nerve block 
in patients with irreversible pulpitis. She found that moderate-to-severe pain may 
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occur 57 % to 89 % of the time with the inferior alveolar nerve block. There was no 
statistical difference between the pain for men or women with respect to needle 
insertion, placement, or deposition. The use of topical anaesthesia did not eliminate 
needle insertion pain. 
Lidocaine is the most frequently used local anesthetic (LA), which contains a 
vasoconstrictor and antioxidant
30
. Commercially available lidocaine solutions with 
epinephrine have a low pH range between 2.9 and 4.4
78
. Decreasing the pH extends 
the shelf life of the solution and prevents its early oxidation
122,80
. However, a low 
pH may produce a burning sensation on the injection site, a slower onset of 
anesthesia, and a decrease in its clinical efficacy
20
. 
Articaine, the second most commonly used dental anesthetic, was first 
introduced to the European market in 1976 and entered the U.S. market in 2000
76 
. 
By 2007, articaine was described as accounting for approximately 25 % of total 
sales, second only to lidocaine at 54 %
107
. The chemical composition of articaine 
contains a unique thiophene ring instead of the benzene ring found in lidocaine and 
other amide local anesthetics. This difference increases lipid solubility, thereby 
increasing diffusion through the lipid membrane of the epineurium, which 
purportedly explains its faster onset and higher success rate when compared with 
lidocaine
21,101
. 
Buffering of LAs (alkalinization) has been suggested to achieve pain 
control
35
. Alkalinization will increase the dissociation rate of the LA molecule and 
then increase the uncharged base form that crosses the nerve membrane to the 
intraneuronal site where it exerts its action
91,49 
. The most common method for 
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buffering of LAs is with the addition of sodium bicarbonate. It is an alkalinizing 
agent, which is most commonly used for the treatment of metabolic acidosis. The 
addition of sodium bicarbonate to LAs not only will increase the pH of the solution 
but will also result in the production of carbon dioxide and water
1
. Carbon dioxide 
potentiates local anesthesia by 3 mechanisms
19,29
. 
1. A direct depressant effect of carbon dioxide on the axon 
2. Concentrating LA inside the nerve trunk (diffusion trapping) 
3. Converting LA to the active cation through its effect on pH at the site of 
action inside the nerve. 
A possible reason for failure is the perineurial barrier around the nervemay 
not allow complete diffusion of the anesthetic solution into the nerve trunk. 
According to de Jong
36, ‘‘the perineurium’s innermost layer, the perilemma, is lined 
with a smooth mesothelial membrane. Tight junctions in the perilemma turn the 
perineurium into a nerve’s main diffusional barrier. Developmentally, the perilemma 
is a continuation of the pia-arachnoid membrane that covers brain and spinal cord, 
hence it is the blood/nerve equivalent of the central blood/brain barrier. These tough 
diffusion barriers lay waste to a substantial proportion of injected local anesthetic 
solution.’’ Under normal conditions, tight junctions along the inner layer of the 
perineurium maintain homeostasis in the endoneurial tissue containing peripheral 
neurons. These tight junctions act as a diffusion barrier not only for high molecular 
weight or hydrophilic substances
112,58,104
, but also for lipophilic compounds
48
. This 
diffusion barrier is continuous along afferent somatic and autonomic  
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nerve fibers to their peripheral endings
33,75
. Inflammation causes a deficiency of the 
perineurial barrier and/or an enhanced permeability of endoneurial capillaries
31,71
. A 
similar disruption of the perineurial barrier can be produced by the extraneural 
application of hyperosmolar solutions
57,142
. Similar to what occurs at the blood brain 
barrier
110
, the effects of hyperosmolar solutions have been linked to a transient 
shrinkage of perineurial cells with subsequent widening of zonulae occludens
31,72
. 
Antonijevic et al
6
. found that a 0.5 M solution of mannitol was most effective in 
opening the perineurial membrane to allow for enhanced penetrability for 
macromolecules and/or ions. They demonstrated that the efficacy of both 
hydrophilic and lipophilic compounds could be improved dramatically by the 
concomitant alteration of perineurial permeability. This effect is short lived, 
reaching a maximum effect at certain concentrations of mannitol and declining at 
higher concentrations
37,39,96,18
. Additionally,there is some evidence that 
hyperosmolar solutions like mannitol delay or block action potential propagation in 
selective A-type neurons in rats
87
. However, the effects on neural conduction of a 
diluted mannitol-lidocaine formulation are unknown. 
The efficacy of buffered local anesthetics has been examined thoroughly in 
medicine. Many of the studies involving buffered anesthetics use the pain of 
injection as their assessment. McKay et al
91
. found that a non-buffered lidocaine 
with epinephrine solution had the higher mean pain score compared to a buffered 
solution. Both lidocaine with commercial epinephrine and plain lidocaine were 
significantly more painful than the corresponding buffered solutions. Steinbrook et 
al.
132
 also studied pain of injection of buffered local anesthetics. They also found 
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that lidocaine buffered with sodium bicarbonate caused significantly less pain on 
skin infiltration.  
Masters et al
86
. also found that the buffered solutions were significantly less 
painful than the control solutions. These authors as well as several other
84,37
 
concluded that pain of injection was reduced by a statistically significant amount 
when using buffered local anesthetics versus non-buffered solutions. These results 
are supported by the results of the systematic review of the literature & meta 
analysis
21,49,54 
that also concluded that buffered local anesthetics result in less pain 
on injection than non-buffered solutions. Some authors were unable to establish any 
significant difference in the pain of injection between buffered and non-buffered 
local anesthetics.  
In this study we used 2 buffers. 8.4% Sodium Bicarbonate most commonly 
used buffer and 0.5 mol/L Mannitol buffer having potential to cross blood brain 
barrier and nerve tissue made them to select them in our study. 2 % lidocaine + 
1:80,000 epinephrine is most commonly used and 4 % articaine + 1:1,00,000 
epinephrine is the second most used local anaesthetic system selected in this study.  
Different methods have been used to determine pulpal anesthetic success. 
Bjorn
14
 was the first to correlate a negative response to maximum output of 
electrical pulp stimulation to painless dental treatment. Dreven et al
37
 evaluated the 
electric pulp tester as a measure of pulpal anesthesia before endodontic treatment in 
teeth with pulpal diagnosis of normal, reversible pulpitis and irreversible pulpitis. 
However, in irreversible pulpitis, the lack of response to vital pulp testing might not 
guarantee pulpal anesthesia. Hence, recording pain response during access 
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preparation and pulp extirpation is a viable alternative
37,99
. All the volunteers in this 
study reported lip numbness after each injection. It should be noted that although all 
the patients had subjective symptoms of lip numbness, the anesthesia was not 
successful in all cases. Literature search revealed that this phenomenon is also seen 
in uninflamed pulps in which, despite successful lip numbness, the clinician failed to 
get no response to the maximum stimulus on electric pulp testing
57,109
. 
Pain measurement is difficult to establish, because its perception and 
intensity are multifactorial, encompassing sensorial and effective factors. 
Quantifying and standardizing pain objectively across a group of individuals can be 
challenging. Numeric and verbal self-rating scales or behavioral observation scales 
have traditionally been used in clinical studies. On the basis of their established 
criteria, the VAS was found to be methodologically sound, conceptually simple, 
easy to administer, and unobtrusive to the respondent. It has a continuous frequency 
distribution allowing for rigorous statistical tests on average pain levels. Heft Parkar 
Visual Analog Scale is a combined metric scale for pain measurement that provides 
the subject with multiple cues that might improve communication and concordance 
between scales for individual pain determination. It integrates irregular spacing of 6 
categorical scale descriptive words onto a 170-mm horizontal line. The inventors 
stressed that patients make categorical judgments on the basis of their understanding 
of the words, and that the categorical ratings are not an ordinal index
7
. Although the 
HP VAS might show deficiencies regarding understanding and perception, it 
provides a validated and meaningful measure of anesthetic efficiency; it is used for 
this purpose by many authors
103
.  
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 All the samples were selected randomly and allocated to sequence generated 
to specific group. Materials used in this study were labeled to blind the individual 
including operator. Randomizing the samples and blinding helped in reducing bias 
in this study. 
Present study results for base line data of 180 patients show no statistical 
difference among all the groups. Patients had to present with symptomatic irreversible 
pulpities and the inflammation taking place within the nervous tissue of their teeth  may 
significantly affect their perception of pain. Studies have reported that preoperative pain 
resulting from symptomatic irreversible pulpitis affects the success rate of the 
conventional IAN block63,129,74,133,113,89,73,111. If one group presented with higher initial 
pain scores than the other, the results of this study could be misleading. The mean initial 
pain reported by the all the groups in this study group showed no significant difference. 
Since, there was no statistically significant difference between the any groups with 
regard to initial pain, this helped to eliminate initial pain as a confounding variable. 
Results of this study showed articaine performed better than lidocaine. 
Lidocaine  has maintained its status as the most widely used local anesthetic in 
dentistry since its introduction. Proven efficacy, low allergenicity, and minimal 
toxicity through clinical use and research have confirmed the value and safety of this 
drug. Thus, it became labeled the gold standard to which all new local anesthetics 
are compared. Despite the gold standard status of lidoocaine, numerous reports have 
advocated the use of articaine hydrochloride as a superior anesthetic agent, primarily 
on the basis of its enhanced anesthetic potency, which is 1.5 times greater than that 
of lidocaine, with faster onset and increased success rate
79
.  
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Articaine, which is 4-methyl-3(2-[propylamino]propionamido)-2-thiophene 
carboxylic acid, methyl ester hydrochloride is the only amide local anesthetic that 
contains a thiophene ring and an additional ester ring
77
. Lipid solubility is an 
intrinsic quality of local anesthetic potency. This quality permits the easier 
penetration of the anesthetic through the lipid nerve membrane and surrounding 
tissues
79
. The degree of anesthetic molecules binding to the nerve membrane was 
suggested to dictate the duration of the anesthetic effect. The more secure a bond is, 
the slower the anesthetic is released from the receptor sites in the sodium channels, 
and the greater the duration of the anesthetic effect. As determined by Courtney et 
al
33
, mere lipid solubility of a local anesthetic did not determine the action on the 
ionic channels. Instead, Uihlein
138
 determined that binding properties of the local 
anesthetic agent to plasma proteins have a greater correlation to action on ionic 
channels than does lipid solubility. Available literature indicates that articaine is 
equally effective in nerve block and infiltration anesthetic techniques when 
compared with other local anesthetics including lidocaine with epinephrine, 
mepivacaine with epinephrine or with levonordefrin, mepivacaine with 
norepinephrine, and prilocaine with epinephrine
147,116,10,136,105
. 
Although IANB is the local anesthesia technique of choice when treating 
mandibular molars, not all IANB injections result in successful pulpal anesthesia. 
The literature provides various explanations to the increased incidence of failure of 
IANB in patients with irreversible pulpitis as we discussed previously in this 
discussion. Articaine contains a thiophene ring instead of a benzene ring found in 
lidocaine, which might allow the molecule to diffuse more readily. This speculation 
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is corroborated by the claims that articaine is able to diffuse through soft and hard 
tissues more reliably than other local anesthetics
92
.  
In this study the anaesthetic effect of  buffered solutions proved to be better 
than non buffered groups. Another explanation why anesthetics fail, relates to the 
theory that the lowered pH of inflamed tissue reduces the amount of the free base form 
of anesthetic to penetrate the nerve membrane. Therefore, there is less of the ionized 
form within the nerve to achieve anesthesia. Most local anesthetics are weak bases with 
pKa  ranging from 7.5 to 9.0. According to Yagiela et al148, “local anesthetics, which are 
acidic, are quickly neutralized by tissue fluid buffers, and a portion of the cationic form 
is converted to the nonionized base”. The amount of the drug that is converted to 
nonionized base form is determined by the Henderson-Hasselbalch equation, which is:  
pH = pKa + log ([A-]/[HA]) 
This equation is dependent on the surrounding body pH and the local anesthetic pKa. 
Buffered local anesthetics have a higher pH and may be more efficient in achieving pain 
control for the inferior alveolar nerve block. Local anesthetics, such as lidocaine & 
articaine have a weak base component, these local anesthetics with epinephrine is a 
mixture of two chemical forms: a non-ionized, uncharged free base form and an ionized, 
and charged cationic form94,16. The non-ionized form of the local anesthetic is the active 
lipid soluble form that readily enters the nerve membrane and blocks nerve 
conduction96. The presence of a sufficient amount of non-ionized free base anesthetic is 
necessary to induce anesthesia. Local anesthetics with epinephrine enters the body at a 
lower pH than that of the physiologic pH of 7.4. At this lower pH, local anaesthtic 
solutions must be buffered by the body to convert enough anesthetic to the de-ionized 
form to produce anesthesia46,137. Creating a solution that is buffered before injection 
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could result in a more effective anesthetic. Galindo45. used buffered local anesthetic 
solutions (pH of 7.4) in peripheral nerve blocks and regional anesthesia. They found 
that higher pH solutions established better quality anesthesia.  
There are several proposed mechanisms for the improved nature of buffered 
anesthetics. One concept involves the idea that a higher pH of injected solution is less 
irritating to the tissues than the more acidic non-buffered conventional solutions83,17. 
Another mechanism states that the de-ionized anesthetic will enter the nerve sheath 
more quickly and result in the afore mentioned faster onset of anesthesia101. Anesthetic 
solutions are buffered with 8.4% sodium bicarbonate and0.05mol/L mannitol, resulting 
in the release of more of de-ionized form of LA. 
The most common technique for the buffering of local anesthetics is by the 
addition of sodium bicarbonate. Each 84 mg of sodium bicarbonate contains 1 mg of 
sodium ions and 1 mg of bicarbonate ions. An 8.4 % solution of sodium bicarbonate 
would contain 1 mEq each of sodium and bicarbonate ions per mL. In this study 8.4 % 
of sodium bicarbonate buffered with both lidicaine & articaine in two of the 
experimental groups. Another technique for the addition for the buffering of  local 
anaesthetics is by the addition of 0.5 mol/L mannitol. In our study lidocaine & 
articaine were also buffered with 0.5 mol/L mannitol in two other experimental 
groups. Both the buffered solutions along with two LA performed well with 
significant results when compared with the non buffered groups but there is no 
significant difference within the buffered groups.   
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SUMMARY 
The aim of this study is to compare the efficacy of two local anesthetic 
solutions buffered with two buffering agents to assess the pain on injection, 
access opening and endodontic instrumentation on the success of inferior 
alveolar nerve block for teeth with symptomatic irreversible pulpitis. 
180 subjects who fulfilled the inclusion and exclusion criteria were chosen 
for the study with no discrimination based on sex, caste, religion or socioeconomic 
status. The complete treatment procedure was explained to the patients and a written 
informed consent was obtained from all the patients selected for the study. The 180 
subjects were randomly divided into 6 groups with 30 participants in each group. 
Blinding has been done by labeling the two local anaesthetic solutions as LA1 & 
LA2 and buffering agents as B1 & B2. The labeled materials were allocated to 
groups randomly as follow:  
1. GROUP I     : 2 % Lignocaine with 1:80,000 Epinephrine 
2. GROUP II    : 4 % Articaine with 1:1,00,000 Epinephrine 
3. GROUP III  : 2 % Lignocaine with 1:80,000 Epinephrine + 0.5 mol/l 
Mannitol 
4. GROUP IV  : 4 % Articaine with 1:1,00,000 Epinephrine + 0.5 mol/l 
Mannitol 
5. GROUP V    : 2 % Lignocaine with 1:80,000 Epinephrine + 8.4 % Sodium 
bicarbonate 
6. GROUP VI  : 4 % Articaine with 1:1,00,000 Epinephrine + 8.4 % Sodium 
bicarbonate 
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Before starting any operative procedure, test dose of local anaesthetic 
solution and buffered solutions will be given for all the participants of respective 
group to check for allergy to any material. The buffered local anaesthetic solution 
should be freshly prepared before injecting The prepared local anaesthetic solution 
injected using conventional IANB to the patient allotted to respective group. Access 
opening done under rubber dam isolation and instrumentation done upto 20 size K 
file till the measured working length. The patients were reviewed immediately for 
Pain on injection, pain on endodontic access cavity preparation and pain on 
endodontic instrumentation after each endodontic procedure to record the values on 
Heft Parker Visual Analog Scale.  
 
The following data were obtained:  
1. Pain on injection 
2. Pain on endodontic access opening 
3. Pain on instrumentation 
All data obtained were tabulated and analysed statistically using statistical software 
SPSS version 22. 
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CONCLUSION 
Within the limitations of this study, the following conclusions can be drawn:  
1. 0.5mol/L Mannitol and 8.4 % sodium bicarbonate proved that adding these 
buffering agents will improve the anaesthetic efficacy of 4 % articaine + 
1:1,00,000 epinephrine than 2 % lignocaine + 1:80,000 epinephrine  
2. 4 % articaine + 1:1,00,000 epinephrine performed better than 2 % lignocaine 
+ 1:80,000 epinephrine in reducing pain during endodontic access opening 
and instrumentation in patients with symptomatic irreversible in mandibular 
posterior teeth using conventional IANB technique 
3. Buffered local anaesthetic solutions found to be promising in reducing pain 
than non buffered solution during endodontic access opening and 
instrumentation in patients with symptomatic irreversible in mandibular 
posterior teeth using conventional IANB technique 
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